Wellington Management Group

Wellington Management Group’s Orchestra BioMed OBIO Stock Holding History

Wellington Management Group’s Portfolio OBIO Stock Details OBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-113,052	Closed	-$1.13M	–	2189
2021 Q4	$1.13M	Sell	113,052 -392,383	-78%	-$3.87M	﹤0.01%	1780
2021 Q3	$5M	Sell	505,435 -120,938	-19%	-$1.19M	﹤0.01%	1509
2021 Q2	$6.39M	Sell	626,373 -12,371	-2%	-$128K	﹤0.01%	1428
2021 Q1	$7.17M	Sell	638,744 -211,256	-25%	-$2.57M	﹤0.01%	1336
2020 Q4	$10.9M	Hold	850,000	–	–	﹤0.01%	1170
2020 Q3	$9.35M	Buy	+850,000	New	+$9.54M	﹤0.01%	1123

Other funds holding OBIO

Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Amitell Capital Singapore $62.4M AUM 75.98% 1-Year Est. Return

Sculptor Capital New York $8.88B AUM 27.49% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return